Literature DB >> 2104904

Identification of enhancer-like elements in human IFN-gamma genomic DNA.

V C Ciccarone1, J Chrivia, K J Hardy, H A Young.   

Abstract

We have previously shown that transfection of a plasmid clone containing full length human IFN-gamma genomic DNA into a murine T-lymphoblastoid line is followed by basal expression of the transfected gene, with increased transcription occurring upon stimulation of the cells with either phorbol ester or IL-2. In addition, upon transfection of this DNA into murine fibroblasts, high level constitutive transcription was observed. In contrast to the results obtained under tissue culture conditions, introduction of the same DNA into the mouse germline resulted in tissue-specific expression of the transgene. We now report identification of a region 500-bp 5' of the human IFN-gamma TATAA box that has strong, PMA-inducible, enhancer-like activity when linked to a reporter gene (CAT) and transfected into a murine T cell line. However, when the same region of IFN-gamma genomic DNA was introduced into NIH-3T3 cells, no enhancer activity was detected either in the presence or absence of PMA. We have further found that an intronic region of the IFN-gamma genomic DNA (nucleotides 405-674) also contains enhancer activity that is functional in either fibroblasts or T cells. Enhancer activity of the intronic region is also PMA-inducible in the mouse T cells but constitutive in fibroblasts. Collectively, our observations suggest that control of human IFN-gamma gene expression is complex, involving noncontiguous regulatory domains in both 5' flanking and intronic regions of that gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104904

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.

Authors:  K A Stellrecht; K Sperber; B G Pogo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

3.  Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer.

Authors:  Anjana Saha; Ashish Dhir; Anand Ranjan; Vibhuti Gupta; Narendra Bairwa; Ramesh Bamezai
Journal:  Immunogenetics       Date:  2005-03-09       Impact factor: 2.846

Review 4.  Regulation of the Ifng locus in the context of T-lineage specification and plasticity.

Authors:  Anand Balasubramani; Ryuta Mukasa; Robin D Hatton; Casey T Weaver
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element.

Authors:  J Ye; M Cippitelli; L Dorman; J R Ortaldo; H A Young
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.

Authors:  A Sica; T H Tan; N Rice; M Kretzschmar; P Ghosh; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 7.  CD154 transcriptional regulation in primary human CD4 T cells.

Authors:  Randy Q Cron
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

9.  Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.

Authors:  Na Gao; Hai-Ling Qiao; Lin-Jing Jia; Xin Tian; Yue-Wen Zhang
Journal:  Eur J Clin Pharmacol       Date:  2008-06-12       Impact factor: 2.953

10.  Superantigens anergize cytokine production but not cytotoxicity in vivo.

Authors:  A Sundstedt; M Dohlsten; G Hedlund; I Höidén; M Björklund; T Kalland
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.